Glaucoma Diagnostic Data Harmonization via Common Scale Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic tests for glaucoma, when used in isolation, lack sufficient accuracy and applicability across the patient population and disease dynamic range, leading to inconsistent and subjective clinical assessments due to test-retest variability and confounding factors.

Innovation Solution

The development of combinatorial analysis techniques that transform measurements from multiple diagnostic tests into a common distribution and scale, using conversion functions and machine learning methods to simplify interpretation, improve diagnostic accuracy, and provide a reliable and objective assessment of glaucoma stage and progression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If multiple diagnostic tests are used in isolation, then each test provides useful information for diagnosis and progression, but the diagnostic accuracy and applicability across patient population and disease dynamic range is insufficient

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidapplicability across patient population
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple diagnostic tests (visual field testing, RNFL analysis, ONH analysis) into a unified combinatorial analysis system. The system integrates data from different test modalities by converting them to a common distribution and scale, then analyzes them together to produce comprehensive diagnostic assessments that improve accuracy across diverse patient populations and disease stages.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The combinatorial analysis system serves multiple functions simultaneously: it detects glaucoma presence, assesses disease stage, monitors progression over time, and provides simplified interpretation of complex multi-test data. This universal approach applies across the entire patient population spectrum from early to advanced disease stages.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Ease of operation

If clinicians correlate results from different tests manually, then clinical assessment can be made, but the task is difficult and subjective with high variability across observers

Engineering Contradiction:
Improveinterpretation processVSAvoidassessment consistency
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system performs automated combinatorial analysis that self-interprets complex multi-test data without requiring manual clinician correlation. The automated algorithm consistently applies the same conversion functions and analysis criteria, eliminating observer variability and providing reliable, reproducible assessments that are easier to operate while maintaining high diagnostic accuracy.

Inventive Principle:
Principle #25Self-service

3Loss of information

If test results are presented in their original formats, then detailed information is available, but the interpretation process becomes complex and time-consuming

Engineering Contradiction:
Improveinformation completenessVSAvoidinterpretation time
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The system extracts key diagnostic information from the complex multi-test data by converting all test results to a common distribution and scale, then identifies and presents only the most clinically relevant findings. This extraction process maintains complete diagnostic information while significantly reducing interpretation time through automated synthesis and simplified presentation of critical results.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentEP2465062B1Glaucoma combinatorial analysis
Publication Date: 2017.12.06 CARL ZEISS MEDITEC AG
  • EP2465062B1 patent drawingFigure 1a
  • EP2465062B1 patent drawingFigure 1b
  • EP2465062B1 patent drawingFigure 2~3

AI summary

The subject invention relates to combinatorial analyses of data from two or more diagnostic tests for the detection of eye diseases, simplified interpretation of test results, and assessment of disease stage and rate of change. Of particular interest is to develop combinatorial analyses to improve glaucoma detection and progression rate assessment based on combinations of structural and functional tests. More specifically, approaches are described where data of one or more tests and their normative database are converted to the distribution and scale of another test for further analysis to detect glaucomatous damage; approaches are also described where data of more than one tests are used to assess stage index and rate of change; in addition, methods for displaying the combinatorial analysis results are disclosed.